drugset / Trial / NCT04749758

Assessment of the Efficacy of Stromal Vascular Fraction Treatment for Knee Osteoarthritis

NCT04749758 ↗

Completed 66 enrolled University of Andorra
NaSingle-groupOpen-labelTreatment

Summary

One-year follow-up prospective observational study involving male and female patients (over 18-years-old) with unilateral or bilateral knee osteoarthritis treated with intraarticular injection of stromal vascular fraction (SVF) treatment. Clinical, biological and radiological data before the treatment and 1-month, 6-month and a year after are collected. The research hypothesis supports that SVF treatment enhance functionality and quality of live, relieves pain and improves magnetic resonance images of joint cartilage in patients with knee osteoarthritis.

Timeline

Start
2018-09-20
Primary completion
2022-12-07
Completion
2022-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Celstem® Cell therapy — Other

Indications